Home Healthcare Biotechnology mRNA Synthesis Raw Material Market

mRNA Synthesis Raw Material Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Natural Nucleic Acids, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production, Others), By End Use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. mRNA Synthesis Raw Material Market Size Analysis
    1. Introduction
    2. mRNA Synthesis Raw Material Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Capping Agents
        1. CleanCap Reagents
        2. ARCA (Anti-Reverse Cap Analog)
        3. Others
      2. Nucleotides
        1. Modified Nucleic Acids
          1. N1-methylpseudouridine-triphosphate
          2. 5-Methylcytidine triphosphate (5mCTP)
          3. Others
      3. Natural Nucleic Acids
        1. Adenine
        2. Guanine
        3. Cytosine
        4. Uracil
      4. Plasmid DNA
      5. Enzymes
        1. Polymerase
        2. RNase Inhibitor
        3. DNase
        4. Others
    3. mRNA Synthesis Raw Material Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Vaccine Production
      2. Therapeutics Production
      3. Others
    4. mRNA Synthesis Raw Material Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Academic & Research Institutes
  7. North America mRNA Synthesis Raw Material Market Size Analysis
    1. Introduction
    2. mRNA Synthesis Raw Material Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Capping Agents
        1. CleanCap Reagents
        2. ARCA (Anti-Reverse Cap Analog)
        3. Others
      2. Nucleotides
        1. Modified Nucleic Acids
          1. N1-methylpseudouridine-triphosphate
          2. 5-Methylcytidine triphosphate (5mCTP)
          3. Others
      3. Natural Nucleic Acids
        1. Adenine
        2. Guanine
        3. Cytosine
        4. Uracil
      4. Plasmid DNA
      5. Enzymes
        1. Polymerase
        2. RNase Inhibitor
        3. DNase
        4. Others
    3. mRNA Synthesis Raw Material Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Vaccine Production
      2. Therapeutics Production
      3. Others
    4. mRNA Synthesis Raw Material Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Academic & Research Institutes
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
  8. Europe mRNA Synthesis Raw Material Market Size Analysis
    1. Introduction
    2. mRNA Synthesis Raw Material Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Capping Agents
        1. CleanCap Reagents
        2. ARCA (Anti-Reverse Cap Analog)
        3. Others
      2. Nucleotides
        1. Modified Nucleic Acids
          1. N1-methylpseudouridine-triphosphate
          2. 5-Methylcytidine triphosphate (5mCTP)
          3. Others
      3. Natural Nucleic Acids
        1. Adenine
        2. Guanine
        3. Cytosine
        4. Uracil
      4. Plasmid DNA
      5. Enzymes
        1. Polymerase
        2. RNase Inhibitor
        3. DNase
        4. Others
    3. mRNA Synthesis Raw Material Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Vaccine Production
      2. Therapeutics Production
      3. Others
    4. mRNA Synthesis Raw Material Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Academic & Research Institutes
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    7. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
  9. APAC mRNA Synthesis Raw Material Market Size Analysis
    1. Introduction
    2. mRNA Synthesis Raw Material Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Capping Agents
        1. CleanCap Reagents
        2. ARCA (Anti-Reverse Cap Analog)
        3. Others
      2. Nucleotides
        1. Modified Nucleic Acids
          1. N1-methylpseudouridine-triphosphate
          2. 5-Methylcytidine triphosphate (5mCTP)
          3. Others
      3. Natural Nucleic Acids
        1. Adenine
        2. Guanine
        3. Cytosine
        4. Uracil
      4. Plasmid DNA
      5. Enzymes
        1. Polymerase
        2. RNase Inhibitor
        3. DNase
        4. Others
    3. mRNA Synthesis Raw Material Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Vaccine Production
      2. Therapeutics Production
      3. Others
    4. mRNA Synthesis Raw Material Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Academic & Research Institutes
    5. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    8. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
  10. Middle East and Africa mRNA Synthesis Raw Material Market Size Analysis
    1. Introduction
    2. mRNA Synthesis Raw Material Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Capping Agents
        1. CleanCap Reagents
        2. ARCA (Anti-Reverse Cap Analog)
        3. Others
      2. Nucleotides
        1. Modified Nucleic Acids
          1. N1-methylpseudouridine-triphosphate
          2. 5-Methylcytidine triphosphate (5mCTP)
          3. Others
      3. Natural Nucleic Acids
        1. Adenine
        2. Guanine
        3. Cytosine
        4. Uracil
      4. Plasmid DNA
      5. Enzymes
        1. Polymerase
        2. RNase Inhibitor
        3. DNase
        4. Others
    3. mRNA Synthesis Raw Material Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Vaccine Production
      2. Therapeutics Production
      3. Others
    4. mRNA Synthesis Raw Material Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Academic & Research Institutes
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
  11. LATAM mRNA Synthesis Raw Material Market Size Analysis
    1. Introduction
    2. mRNA Synthesis Raw Material Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Capping Agents
        1. CleanCap Reagents
        2. ARCA (Anti-Reverse Cap Analog)
        3. Others
      2. Nucleotides
        1. Modified Nucleic Acids
          1. N1-methylpseudouridine-triphosphate
          2. 5-Methylcytidine triphosphate (5mCTP)
          3. Others
      3. Natural Nucleic Acids
        1. Adenine
        2. Guanine
        3. Cytosine
        4. Uracil
      4. Plasmid DNA
      5. Enzymes
        1. Polymerase
        2. RNase Inhibitor
        3. DNase
        4. Others
    3. mRNA Synthesis Raw Material Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Vaccine Production
      2. Therapeutics Production
      3. Others
    4. mRNA Synthesis Raw Material Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Academic & Research Institutes
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
  12. Competitive Landscape
    1. mRNA Synthesis Raw Material Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Thermo Fisher Scientific Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Merck KGaA
    3. Maravai LifeSciences
    4. New England Biolabs
    5. GenScript
    6. Takara Bio Inc.
    7. Glen Research
    8. CordenPharma
    9. Catalent, Inc
    10. Evonik Industries AG
    11. Lonza
    12. Agilent Technologies, Inc.
    13. Bio-Rad Laboratories, Inc.
    14. Silantes GmbH
    15. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.